• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006 - 2015年芬兰老年结直肠癌患者的短期和长期生存情况:一项基于全国人口登记的研究

Short- and Long-Term Survival among Elderly Colorectal Cancer Patients in Finland, 2006-2015: A Nationwide Population-Based Registry Study.

作者信息

Hukkinen Tanja, Olenius Tobias, Koskensalo Selja, Lepistö Anna, Koskenvuo Laura, Böckelman Camilla

机构信息

Department of Gastroenterological Surgery, Abdominal Center, Helsinki University Hospital, Faculty of Medicine, University of Helsinki, Meilahden Sairaalakampus, Palvelukeskus PAKE.PA3.30, Stenbäckinkatu 9A, PL 440, 00029 Helsinki, Finland.

出版信息

Cancers (Basel). 2023 Dec 27;16(1):135. doi: 10.3390/cancers16010135.

DOI:10.3390/cancers16010135
PMID:38201562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10777947/
Abstract

This population-based registry study aimed to report 30-day and one-year postoperative survival, five-year overall survival (OS), and disease-specific survival (DSS) among elderly (≥75 years old) colorectal cancer (CRC) patients. All new colorectal cancer cases from 2006-2015 were included and followed until death or the end of follow-up (end of 2016). Among 27,088 CRC patients, 11,306 patients were ≥75 years old. Among patients ≥ 75 years, 36.8% ( = 4160) had right-sided colon cancer, 21.9% ( = 2478) left-sided colon cancer, and 32.3% ( = 3650) rectal cancer. In this study population, 932 patients were aged ≥ 90. The 30-day postoperative OS for patients aged 75-79 was 96.1% (95% confidence interval [CI] 95.3-96.9) falling to 93.2% (95% CI 92.0-94.4) for patients aged 80-84. The one-year postoperative OS among patients aged 75-79 was 86.3% (95% CI 84.7-87.9) compared with 80.5% (95% CI 78.7-82.3) among patients aged 80-84. Five-year OS among patients aged 75-79 was 47.6% (95% CI 46.0-49.2) and 36.6% (95% CI 34.8-38.4) among patients aged 80-84, compared with 61.7% (95% CI 60.9-62.5) among younger patients (<75 years old). Survival among elderly CRC patients (≥75 years old) was in general fairly good when compared with younger patients, especially among patients aged 75-79 and 80-84 with localized or locally advanced disease.

摘要

这项基于人群的登记研究旨在报告老年(≥75岁)结直肠癌(CRC)患者术后30天和1年生存率、5年总生存率(OS)和疾病特异性生存率(DSS)。纳入了2006年至2015年所有新诊断的结直肠癌病例,并随访至死亡或随访结束(2016年底)。在27,088例CRC患者中,11,306例患者年龄≥75岁。在≥75岁的患者中,36.8%(=4160)患有右半结肠癌,21.9%(=2478)患有左半结肠癌,32.3%(=3650)患有直肠癌。在该研究人群中,932例患者年龄≥90岁。75至79岁患者术后30天OS为96.1%(95%置信区间[CI]95.3 - 96.9),80至84岁患者降至93.2%(95%CI 92.0 - 94.4)。75至79岁患者术后1年OS为86.3%(�5%CI 84.7 - 87.9),而80至84岁患者为80.5%(95%CI 78.7 - 82.3)。75至79岁患者5年OS为47.6%(95%CI 46.0 - 49.2),80至84岁患者为36.6%(95%CI 34.8 - 38.4),相比之下,年轻患者(<75岁)为61.7%(95%CI 60.9 - 62.5)。与年轻患者相比,老年CRC患者(≥75岁)的生存率总体相当不错,尤其是75至79岁和80至84岁患有局限性或局部晚期疾病的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/698ac7081ba3/cancers-16-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/91739423ba43/cancers-16-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/ad634a1a0c98/cancers-16-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/d78d08b80143/cancers-16-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/698ac7081ba3/cancers-16-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/91739423ba43/cancers-16-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/ad634a1a0c98/cancers-16-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/d78d08b80143/cancers-16-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4156/10777947/698ac7081ba3/cancers-16-00135-g004.jpg

相似文献

1
Short- and Long-Term Survival among Elderly Colorectal Cancer Patients in Finland, 2006-2015: A Nationwide Population-Based Registry Study.2006 - 2015年芬兰老年结直肠癌患者的短期和长期生存情况:一项基于全国人口登记的研究
Cancers (Basel). 2023 Dec 27;16(1):135. doi: 10.3390/cancers16010135.
2
Long-term survival among colorectal cancer patients in Finland, 1991-2015: a nationwide population-based registry study.芬兰 1991-2015 年结直肠癌患者的长期生存情况:一项基于全国人口的登记研究。
BMC Cancer. 2022 Apr 2;22(1):356. doi: 10.1186/s12885-022-09460-0.
3
Colorectal cancer liver metastases - a population-based study on incidence, management and survival.结直肠癌肝转移-基于人群的发病率、治疗和生存研究。
BMC Cancer. 2018 Jan 15;18(1):78. doi: 10.1186/s12885-017-3925-x.
4
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
5
Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.III 期结直肠癌原发肿瘤位置对预后的影响:右半结肠与左半结肠和直肠的全国多中心回顾性研究。
J Gastroenterol. 2020 Oct;55(10):958-968. doi: 10.1007/s00535-020-01706-7. Epub 2020 Jul 10.
6
A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.通过综合错配修复状态、肿瘤位置和结直肠癌患者发病年龄等因素,可以看出其与生存率之间的关系。
PLoS One. 2017 Mar 2;12(3):e0172799. doi: 10.1371/journal.pone.0172799. eCollection 2017.
7
Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.结直肠癌肝转移肝切除术后KRAS状态的预后意义因原发性结直肠癌肿瘤位置而异。
Ann Surg Oncol. 2016 Oct;23(11):3736-3743. doi: 10.1245/s10434-016-5361-6. Epub 2016 Jun 28.
8
Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.手术及辅助治疗对老年结直肠癌患者的疗效:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2014 Dec;93(28):e266. doi: 10.1097/MD.0000000000000266.
9
Right sided colorectal cancer increases with age and screening should be tailored to reflect this: a national cancer database study.右半结直肠癌随年龄增长而增加,筛查应针对这一点进行调整:一项国家癌症数据库研究。
Tech Coloproctol. 2021 Jan;25(1):81-89. doi: 10.1007/s10151-020-02329-z. Epub 2020 Aug 27.
10
Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.结直肠癌肝转移患者原发肿瘤部位的预后价值:右半结肠、左半结肠和直肠的比较。
Dis Colon Rectum. 2023 Feb 1;66(2):233-242. doi: 10.1097/DCR.0000000000002228. Epub 2022 Dec 27.

引用本文的文献

1
Clinical Frailty Scale predicts overall survival after colon cancer surgery in people aged 80 years and older: A prospective multicentre observational study.临床衰弱量表可预测80岁及以上人群结肠癌手术后的总生存期:一项前瞻性多中心观察性研究。
Colorectal Dis. 2025 Aug;27(8):e70190. doi: 10.1111/codi.70190.
2
Incidence, characteristics, and survival in early- and late-onset colorectal cancer.早发性和晚发性结直肠癌的发病率、特征及生存率
Acta Oncol. 2025 Jul 30;64:997-1004. doi: 10.2340/1651-226X.2025.43349.
3
Onset and prognostic features of anastomotic leakage in patients undergoing radical surgery after neoadjuvant chemoradiation for rectal cancer.

本文引用的文献

1
Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer.老年结直肠癌患者手术和辅助治疗生存获益的真实世界分析。
Sci Rep. 2023 Sep 8;13(1):14866. doi: 10.1038/s41598-023-41713-1.
2
Association of age with outcomes in locally advanced rectal cancer treated with neoadjuvant therapy followed by surgery.年龄与新辅助治疗后手术治疗局部晚期直肠癌结局的关系。
Am J Surg. 2023 Jun;225(6):1029-1035. doi: 10.1016/j.amjsurg.2022.12.002. Epub 2022 Dec 14.
3
Impact of age and comorbidities on short- and long-term outcomes of patients undergoing surgery for colorectal cancer.
新辅助放化疗后行根治性手术的直肠癌患者吻合口漏的发病情况及预后特征
World J Gastrointest Surg. 2024 Dec 27;16(12):3710-3719. doi: 10.4240/wjgs.v16.i12.3710.
年龄和合并症对接受结直肠癌手术患者短期和长期预后的影响。
Front Oncol. 2022 Oct 21;12:959650. doi: 10.3389/fonc.2022.959650. eCollection 2022.
4
Long-term survival among colorectal cancer patients in Finland, 1991-2015: a nationwide population-based registry study.芬兰 1991-2015 年结直肠癌患者的长期生存情况:一项基于全国人口的登记研究。
BMC Cancer. 2022 Apr 2;22(1):356. doi: 10.1186/s12885-022-09460-0.
5
Octogenarian patients with colon cancer - postoperative morbidity and mortality are the major challenges.80 岁以上的结肠癌患者 - 术后发病率和死亡率是主要的挑战。
BMC Cancer. 2022 Mar 21;22(1):302. doi: 10.1186/s12885-022-09384-9.
6
Right colon, left colon, and rectal cancer have different oncologic and quality of life outcomes.右半结肠癌、左半结肠癌和直肠癌的肿瘤学和生活质量结局不同。
Int J Colorectal Dis. 2022 Apr;37(4):939-948. doi: 10.1007/s00384-022-04121-x. Epub 2022 Mar 21.
7
Colon cancer survival differs from right side to left side and lymph node harvest number matter.结直肠癌的生存情况因肿瘤发生位置(右侧和左侧)和淋巴结清扫数目而异。
BMC Public Health. 2021 May 12;21(1):906. doi: 10.1186/s12889-021-10746-4.
8
The Clinical Frailty Scale is a useful tool for predicting postoperative complications following elective colon cancer surgery at the age of 80 years and above: A prospective, multicentre observational study.临床虚弱量表是预测 80 岁及以上择期结肠癌手术后术后并发症的有用工具:一项前瞻性、多中心观察性研究。
Colorectal Dis. 2021 Jul;23(7):1824-1836. doi: 10.1111/codi.15689. Epub 2021 May 15.
9
Accuracy of Finnish Cancer Registry colorectal cancer data: a comparison between registry data and clinical records.芬兰癌症登记处结直肠癌数据的准确性:登记处数据与临床记录的比较。
Scand J Gastroenterol. 2021 Mar;56(3):247-251. doi: 10.1080/00365521.2020.1867893. Epub 2021 Jan 6.
10
A scoping review of the Clinical Frailty Scale.临床虚弱量表的范围综述。
BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7.